Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... Obesity and Diabetes, Rosiglitazone, Thazolidinedione, Type 2 Diabetes Mellitus, Vasodilator Agent. This article was prepared by Biotech Business Week editors from staff and ...
2009 NOV 16 ... human EPCs leading to NO generation. IGFBP-3 exposure also led to the redistribution of vasodilator-stimulated phosphoprotein, an NO regulated protein critical for cell migration. ... The researchers concluded: "These studies support consideration of IGFBP-3 as a novel agent to restore the function of injured vasculature and restore NO generation. (Circ Res. ...
2009 NOV 23 ... Mellitus, Rosiglitazone, Thazolidinedione, Therapy, Treatment, Type 2 Diabetes Mellitus, Vasodilator Agent, Weight Gain, Wellness. This article was prepared by Biotech Business Week ...
2009 NOV 23 ... Drug Resistance, Drugs, Pharmaceuticals, Stem Cell Research, Therapy, Treatment, Vasodilator Agent, Verapamil, National Cheng-Kung University. This article was prepared by ...
2009 NOV 23 ... City:Zagreb, Country:Croatia, Hypertension, Phosphodiesterase Inhibitor, Sildenafil, Vasodilator Agent. This article was prepared by Biotech Business Week editors from staff and ...
2009 NOV 23 ... Dysfunction, Impotence, Regulatory Actions, Sildenafil, Phosphodiesterase Inhibitor, Vasodilator Agent, Public Health, Harvard University, Medical Department. This article was ...
2009 NOV 23 ... Drugs, Metoprolol, Pharmaceuticals, Sympatholytic, Tachycardia, Therapy, Treatment, Vasodilator Agent, Ventricular Tachycardia. This article was prepared by Biotech Business ...
2009 NOV 16 ... Pharmacodynamics, Pharmacokinetics, Pharmacological, Telithromycin, Therapy, Treatment, Vasodilator Agent, Verapamil, University of Louvain. This article was prepared by ...
2009 NOV 23 ... Agent, Physiology, Polycystic Ovarian Syndrome, Rosiglitazone, Thazolidinedione, Vasodilator Agent, Women's Health, University of Guelph. This article was prepared by ...
2009 NOV 16 ... Pharmaceuticals, Supraventricular Tachycardia, Tachycardia, Therapy, Treatment, Vasodilator Agent, Verapamil, Istanbul University. This article was prepared by Biotech ...
2009 NOV 23 ... Pulmonary Hypertension, Pulmonology, Sildenafil, Simvastatin, Therapy, Treatment, Vasodilator Agent, University of London, Imperial College. This article was prepared by ...
2009 NOV 16 ... Proteins, Proteomics, Rosiglitazone, Thazolidinedione, Type 2 Diabetes Mellitus, Vasodilator Agent, Maastricht University. This article was prepared by Biotech Business Week ...
2009 NOV 23 ... Surgical Technology, Sympathomimetic, Synthase, Therapy, Treatment, Vasoconstrictor A, Vasodilator Agent, Cumhuriyet University, Medical Department. This article was prepared by ...
2009 NOV 16 ... Storage Disease, Hypertension, Phosphodiesterase Inhibitor, Sildenafil, Syncope, Vasodilator Agent, Hokkaido University. This article was prepared by Biotech Business Week ...
2009 NOV 16 ... Myocardial Infarction, Nitric Oxide, Pharmaceuticals, Synthase, Therapy, Treatment, Vasodilator Agent, Ventricular Fibrillation, Verapamil, University of Western Ontario. This ...
2009 NOV 16 ... Enzymes, Hypertension, Phosphodiesterase Inhibitor, Phosphodiesterases, Sildenafil, Vasodilator Agent, Tongji University. This article was prepared by Biotech Business Week ...
